Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials.
Innovation plays an important role in overcoming global challenges and is a key driver of future growth at Bayer.
With our distinctive knowledge of people, animals, plants and materials, we intend to focus in future on the areas of health care, nutrition and high-tech materials.
Read more about our economic, ecological and social challenges and opportunities.
This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
We want to create value for our shareholders through innovation, growth and high earning power.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
Location: Leverkusen, BayKomm (Bayer‘s Communication Center)
Dr. Marijn Dekkers,
CEO of Bayer AG
CFO of Bayer AG
Dynamic development in the Life Science businesses, MaterialScience below expectations / Outstanding growth for recently launched pharmaceutical products – estimate of combined peak annual sales potential for the five products increased to at least EUR 7.5 billion / Group sales EUR 40,157 million (plus 1.0 percent; Fx & portfolio adj.: plus 5.1 percent) / EBIT advanced by 25.6 percent to EUR 4,934 million / EBITDA before special items up by 1.5 percent to EUR 8,401 million / Net income increased 32.7 percent to EUR 3,189 million / Core earnings per share up 5.8 percent to EUR 5.61 / Forecast for 2014: further growth in sales and earnings more
Annual Report 2013
Speech in written form and presentation slides of Dr. Marijn DekkersSpeech in written form and presentation slides of Werner BaumannPress kitNotice of the Annual Stockholders' Meeting 2014
Video with slides:
Introduction of Dr. Herbert HeitmannSpeech of Dr. Marijn Dekkers (part 1)Speech of Werner BaumannSpeech of Dr. Marijn Dekkers (part 2)Discussion
Speech of Dr. Marijn Dekkers (part 1, 14.9 MB, 31:49 min.)Speech of Werner Baumann (6.2 MB, 13:08 min.)Speech of Dr. Marijn Dekkers (part 2, 4.8 MB, 10:09 min.)Discussion (34.3 MB, 73:08 min.)
Coverage of the Financial News Conference on twitter. The corresponding hashtag is #BFNC14
Subscribe to our Bayer Group Events podcast via RSS or iTunes.